Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets
Science Advances · 06.10.2023 · 9 (40)
DOI: 10.1126/sciadv.adf0837 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Science Advances, erschienen am 06.10.2023. Verfasst von Guan-Hua Su und 11 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center and Department of Oncology, Shangh…. Hauptthemen laut MEDLINE: Multiomics, Breast Neoplasms. Die Arbeit wurde bisher 141-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Intratumor heterogeneity (ITH) profoundly affects therapeutic responses and clinical outcomes. However, the widespread methods for assessing ITH based on genomic sequencing or pathological slides, which rely on limited tissue samples, may lead to inaccuracies due to potential sampling biases. Using a newly established multicenter breast cancer radio-multiomic dataset ( n = 1474) encompassing radiomic features extracted from dynamic contrast–enhanced magnetic resonance images, we formulated a noninvasive radiomics methodology to effectively investigate ITH. Imaging ITH (IITH) was associated with genomic and pathological ITH, predicting poor prognosis independently in breast cancer. Through multiomic analysis, we identified activated oncogenic pathways and metabolic dysregulation in high-IITH tumors. Integrated metabolomic and transcriptomic analyses highlighted ferroptosis as a vulnerability and potential therapeutic target of high-IITH tumors. Collectively, this work emphasizes the superiority of radiomics in capturing ITH. Furthermore, we provide insights into the biological basis of IITH and propose therapeutic targets for breast cancers with elevated IITH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center and Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
- Department of Radiology, Fudan University Shanghai Cancer Center and Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
- Institute of Science and Technology for Brain-inspired Intelligence, Fudan University, Shanghai 201203, China.
ORCID-Profile: Guan-Hua Su, Yi Xiao, Chao You, Ren-Cheng Zheng, Shen Zhao, Shi-Yun Sun, Jia-Yin Zhou, He Wang, Zhi-Ming Shao, Ya-Jia Gu, Yi-Zhou Jiang
Zitieren
APA
Su, G. H., Xiao, Y., You, C., Zheng, R. C., Zhao, S., Sun, S. Y., Zhou, J. Y., Lin, L. Y., Wang, H., Shao, Z. M., Gu, Y. J., & Jiang, Y. Z. (2023). Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets. Science Advances, 9(40). https://doi.org/10.1126/sciadv.adf0837
Vancouver
Su GH, Xiao Y, You C, Zheng RC, Zhao S, Sun SY, et al. Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets. Science Advances. 2023;9(40). doi:10.1126/sciadv.adf0837
BibTeX
@article{Su2023,
author = {Su, Guan-Hua and Xiao, Yi and You, Chao and Zheng, Ren-Cheng and Zhao, Shen and Sun, Shi-Yun and Zhou, Jia-Yin and Lin, Lu-Yi and Wang, He and Shao, Zhi-Ming and Gu, Ya-Jia and Jiang, Yi-Zhou},
title = {Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets},
journal = {Science Advances},
year = {2023},
volume = {9},
number = {40},
doi = {10.1126/sciadv.adf0837}
}
EUVIMED